Insider transactions

EDGAR

Astrana Health, Inc.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-21.

Open-market purchases (code P)
0 transactions, — shares
Open-market sales (code S)
0 transactions, — shares

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–42 of 42

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-11-12 Filed 2026-11-13Vong John Officer: SVP - Accounting (PAO)
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)64231.77
20,396.34

Derived: shares × price per share. Exact value 20396.34.

21,132Direct (D) No
F1, F2, F3
  • F1 Represents the surrender of shares to offset against tax withholding obligations associated with certain shares of restricted stock that vested on November 12, 2026.
  • F2 Includes 2,176 shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 380 shares which will vest on November 30, 2026; and (ii) tranches of 227 shares, 227 shares, 227 shares, 227 shares, and 888 shares, each of which will vest on May 12, 2027. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 1,552 restricted stock units, which will vest on April 10, 2027; and (ii) 1,887 restricted stock units, which will vest in seven equal semi-annual installments beginning March 15, 2027.
  • F3 Includes 584 shares acquired under the Issuer's Employee Stock Purchase Plan.
Open filing 0001104659-26-127074 Read from the filing’s XML Dispute this row
2026-10-10 Filed 2026-10-13Vong John Officer: SVP - Accounting (PAO)
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)55637.55
20,877.8

Derived: shares × price per share. Exact value 20877.80.

21,774Direct (D) No
F1, F2, F3
  • F1 Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock units that vested on October 10, 2026.
  • F2 Includes 3,972 shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 380 shares which will vest on November 30, 2026; and (ii) tranches of 454 shares, 454 shares, 454 shares, 454 shares, and 1,776 shares, each of which will vest in two equal semi-annual installments beginning on November 12, 2026. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 1,552 restricted stock units, which will vest on April 10, 2027; and (ii) 1,887 restricted stock units, which will vest in seven equal semi-annual installments beginning March 15, 2027.
  • F3 Includes 584 shares acquired under the Issuer's Employee Stock Purchase Plan.
Open filing 0001104659-26-115507 Read from the filing’s XML Dispute this row
2026-10-06 Filed 2026-10-08Lam Thomas S. Director
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)2,62437.00
97,088

Derived: shares × price per share. Exact value 97088.00.

463,033Direct (D) No
F2, F3
  • F2 Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock units that vested on October 6, 2026.
  • F3 Includes the following shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer and/or its affiliates): (i) 51,667 shares, which will vest in two equal annual installments beginning on March 5, 2027; and (ii) 13,334 shares, which will vest in two equal annual installments beginning on April 1, 2027. Also includes 36,459 restricted stock units, which will vest in seven equal semi-annual installments beginning on April 6, 2027 (subject to continuous employment with the Issuer and/or its affiliates).
Open filing 0001104659-26-114777 Read from the filing’s XML Dispute this row
2026-10-06 Filed 2026-10-08Sim Brandon Officer: CEO and President
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)9,88937
365,893

Derived: shares × price per share. Exact value 365893.

1,228,972Direct (D) No
F3, F4, F5
  • F3 Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock units that vested on October 6, 2026.
  • F4 Includes 17,105 shares of unvested restricted stock, which will vest on March 31, 2027, subject to continuous employment with the Issuer. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 45,261 restricted stock units, which will vest in three equal semi-annual installments beginning on April 2, 2027; (ii) 91,027 restricted stock units, which will vest in five equal semi-annual installments beginning on March 5, 2027; and (iii) 175,924 restricted stock units, which will vest in seven equal semi-annual installments beginning on April 6, 2027.
  • F5 Includes 2,152 shares acquired under the Issuer's Employee Stock Purchase Plan.
Open filing 0001104659-26-114785 Read from the filing’s XML Dispute this row
2026-10-02 Filed 2026-10-06Basho Chandan Officer: COO and CFO
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)2,09235.88
75,060.96

Derived: shares × price per share. Exact value 75060.96.

155,728Direct (D) No
F1, F2
  • F1 Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock units that vested on October 2, 2026.
  • F2 Includes 15,202 shares of unvested restricted stock which will vest on May 16, 2027 (subject to continuous employment with the Issuer). Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 11,703 restricted stock units, which will vest in three equal semi-annual installments beginning on April 2, 2027; and (ii) 16,690 restricted stock units, which will vest in five equal semi-annual installments beginning on March 5, 2027.
Open filing 0001104659-26-113838 Read from the filing’s XML Dispute this row
2026-09-15 Filed 2026-09-17Vong John Officer: SVP - Accounting (PAO)
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)9638.35
3,681.6

Derived: shares × price per share. Exact value 3681.60.

22,330Direct (D) No
F1, F2, F3
  • F1 Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock units that vested on September 15, 2026.
  • F2 Includes 3,972 shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 380 shares which will vest on November 30, 2026; and (ii) tranches of 454 shares, 454 shares, 454 shares, 454 shares, and 1,776 shares, each of which will vest in two equal semi-annual installments beginning on November 12, 2026. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 3,104 restricted stock units, which will vest in two equal semi-annual installments beginning on October 10, 2026; and (ii) 1,887 restricted stock units, which will vest in seven equal semi-annual installments beginning March 15, 2027.
  • F3 Includes 584 shares acquired under the Issuer's Employee Stock Purchase Plan.
Open filing 0001104659-26-108627 Read from the filing’s XML Dispute this row
2026-09-05 Filed 2026-09-09Sim Brandon Officer: CEO and President
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)7,16338.47
275,560.61

Derived: shares × price per share. Exact value 275560.61.

1,238,861Direct (D) No
F3, F4, F5
  • F3 Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock units that vested on September 5, 2026.
  • F4 Includes 34,207 shares of unvested restricted stock, which will vest in two equal semi-annual installments, beginning September 30, 2026, subject to continuous employment with the Issuer. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 60,347 restricted stock units, which will vest in four equal semi-annual installments beginning on October 2, 2026; (ii) 91,027 restricted stock units, which will vest in five equal semi-annual installments beginning on March 5, 2027; and (iii) 201,056 restricted stock units, which will vest in eight equal semi-annual installments beginning on October 6, 2026.
  • F5 Includes 2,152 shares acquired under the Issuer's Employee Stock Purchase Plan.
Open filing 0001104659-26-106325 Read from the filing’s XML Dispute this row
2026-09-05 Filed 2026-09-08Basho Chandan Officer: COO and CFO
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)1,79038.47
68,861.3

Derived: shares × price per share. Exact value 68861.30.

157,820Direct (D) No
F1, F2
  • F1 Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock units that vested on September 5, 2026.
  • F2 Includes 15,202 shares of unvested restricted stock which will vest on May 16, 2027 (subject to continuous employment with the Issuer). Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 15,604 restricted stock units, which will vest in four equal semi-annual installments beginning on October 2, 2026; and (ii) 16,690 restricted stock units, which will vest in five equal semi-annual installments beginning on March 5, 2027.
Open filing 0001104659-26-105932 Read from the filing’s XML Dispute this row
2026-08-31 Filed 2026-09-01Kitayama Mitchell W Director
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Common Stock
Disposed (D)8,50037.09
315,265

Derived: shares × price per share. Exact value 315265.00.

24,337Direct (D) No
F1, F2
  • F1 These shares were repurchased by the Issuer.
  • F2 Includes 4,991 shares of restricted stock, which will vest on the earlier of June 10, 2027 or the date of the Issuer's 2027 annual meeting of stockholders.
Open filing 0001104659-26-104397 Read from the filing’s XML Dispute this row
2026-08-14 Filed 2026-08-18Schmidt David Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)20,0005.0
100,000

Derived: shares × price per share. Exact value 100000.0.

56,019Direct (D) No— Open filing 0001104659-26-098353 Read from the filing’s XML Dispute this row
2026-08-14 Filed 2026-08-18Schmidt David Director
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Common Stock
Disposed (D)20,00038.59
771,800

Derived: shares × price per share. Exact value 771800.00.

36,019Direct (D) No
F1, F2
  • F1 These shares were repurchased by the Issuer.
  • F2 Includes 4,525 shares of restricted stock, which will vest on the earlier of June 10, 2027 or the date of the Issuer's 2027 annual meeting of stockholders.
Open filing 0001104659-26-098353 Read from the filing’s XML Dispute this row
2026-08-14 Filed 2026-08-18Schmidt David Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (right to Buy) — underlying Common Stock (20,000) — exercise price 5.0
Disposed (D)20,0000—0Direct (D) No
F3
  • F3 These stock options were fully vested and exercisable.
Open filing 0001104659-26-098353 Read from the filing’s XML Dispute this row
2026-08-07 Filed 2026-08-11Sobotka Glenn Other: Former Officer
D

Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Common Stock
Disposed (D)11,7930—2,246Direct (D) No
F1, F2
  • F1 Represents the surrender of unvested time-based and performance-based restricted stock that was forfeited in connection with the reporting person's retirement from his positions with the Issuer.
  • F2 Includes 1,300 shares of restricted stock that will vest on an accelerated basis in connection with the reporting person's retirement from his positions with the Issuer, subject to his execution of a release of claims.
Open filing 0001104659-26-094142 Read from the filing’s XML Dispute this row
2026-06-27 Filed 2026-06-30Sim Brandon Officer: CEO and President
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)1,09344.51
48,649.43

Derived: shares × price per share. Exact value 48649.43.

1,245,292Direct (D) No
F3, F4, F5
  • F3 Represents the surrender of shares to offset against tax withholding obligations associated with the vesting of certain shares of restricted stock.
  • F4 Includes 34,207 shares of unvested restricted stock, which will vest in two equal semi-annual installments, beginning September 30, 2026, subject to continuous employment with the Issuer. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 60,347 restricted stock units, which will vest in four equal semi-annual installments beginning on October 2, 2026; (ii) 109,232 restricted stock units, which will vest in six equal semi-annual installments beginning on September 5, 2026; and (iii) 201,056 restricted stock units, which will vest in eight equal semi-annual installments beginning on October 6, 2026.
  • F5 Includes 1,420 shares acquired under the Issuer's Employee Stock Purchase Plan.
Open filing 0001104659-26-079333 Read from the filing’s XML Dispute this row
2026-06-10 Filed 2026-06-12Mazdyasni Matthew Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)4,5250—39,288Direct (D) No
F1, F2
  • F1 Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2024 Equity Incentive Plan, which will vest on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders.
  • F2 Includes 4,525 shares of restricted stock, which will vest on the earlier of June 10, 2027 or the date of the Issuer's 2027 annual meeting of stockholders.
Open filing 0001104659-26-073488 Read from the filing’s XML Dispute this row
2026-06-10 Filed 2026-06-12Kitayama Mitchell W Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)4,9910—32,837Direct (D) No
F1, F2
  • F1 Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2024 Equity Incentive Plan, which will vest on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders.
  • F2 Includes 4,991 shares of restricted stock, which will vest on the earlier of June 10, 2027 or the date of the Issuer's 2027 annual meeting of stockholders.
Open filing 0001104659-26-073485 Read from the filing’s XML Dispute this row
2026-06-10 Filed 2026-06-12Schmidt David Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)4,5250—36,019Direct (D) No
F1, F2
  • F1 Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2024 Equity Incentive Plan, which will vest on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders.
  • F2 Includes 4,525 shares of restricted stock, which will vest on the earlier of June 10, 2027 or the date of the Issuer's 2027 annual meeting of stockholders.
Open filing 0001104659-26-073493 Read from the filing’s XML Dispute this row
2026-06-10 Filed 2026-06-12Chiang John Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)4,5250—35,373Direct (D) No
F1, F2
  • F1 Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2024 Equity Incentive Plan, which will vest on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders.
  • F2 Includes 4,525 shares of restricted stock, which will vest on the earlier of June 10, 2027 or the date of the Issuer's 2027 annual meeting of stockholders.
Open filing 0001104659-26-073467 Read from the filing’s XML Dispute this row
2026-06-10 Filed 2026-06-12Dong Linda Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)4,5250—97,133Direct (D) No
F1, F2
  • F1 Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2024 Equity Incentive Plan, which will vest on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders.
  • F2 Includes 4,525 shares of restricted stock, which will vest on the earlier of June 10, 2027 or the date of the Issuer's 2027 annual meeting of stockholders.
Open filing 0001104659-26-073484 Read from the filing’s XML Dispute this row
2026-06-10 Filed 2026-06-12Dai, Weili Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)4,5250—18,188Direct (D) No
F1, F2
  • F1 Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2024 Equity Incentive Plan, which will vest on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders.
  • F2 Includes 4,525 shares of restricted stock, which will vest on the earlier of June 10, 2027 or the date of the Issuer's 2027 annual meeting of stockholders.
Open filing 0001104659-26-073475 Read from the filing’s XML Dispute this row
2026-05-16 Filed 2026-05-18Basho Chandan Officer: COO and CFO
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)8,15538.26
312,010.3

Derived: shares × price per share. Exact value 312010.30.

159,610Direct (D) No
F1, F2
  • F1 Represents the surrender of shares to offset against tax withholding obligations associated with certain shares of restricted stock that vested on May 16, 2026.
  • F2 Includes 15,202 shares of unvested restricted stock which will vest on May 16, 2027 (subject to continuous employment with the Issuer). Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 15,604 restricted stock units, which will vest in four equal semi-annual installments beginning on October 2, 2026; and (ii) 20,027 restricted stock units, which will vest in six equal semi-annual installments beginning on September 5, 2026.
Open filing 0001104659-26-063197 Read from the filing’s XML Dispute this row
2026-04-14 Filed 2026-04-15Basho Chandan Officer: COO and CFO
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)3,87029.07
112,500.9

Derived: shares × price per share. Exact value 112500.90.

167,765Direct (D) No
F1, F2
  • F1 Represents the surrender of shares to offset against tax withholding obligations associated with certain shares of restricted stock that vested on April 14, 2026.
  • F2 Includes 30,404 shares of unvested restricted stock, which will vest in two equal annual installments on May 16, 2026 and 2027 (subject to continuous employment with the Issuer). Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 15,604 restricted stock units, which will vest in four equal semi-annual installments beginning on October 2, 2026; and (ii) 20,027 restricted stock units, which will vest in six equal semi-annual installments beginning on September 5, 2026.
Open filing 0001104659-26-043808 Read from the filing’s XML Dispute this row
2026-04-06 Filed 2026-04-08Lam Thomas S. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)41,6670—465,657Direct (D) No
F2, F3
  • F2 Represents a grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Provided the Reporting Person is still employed with the Issuer and/or its affiliates on the date of vesting, the shares shall vest in eight equal semi-annual installments beginning on October 6, 2026.
  • F3 Includes the following shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer and/or its affiliates): (i) 51,667 shares, which will vest in two equal annual installments beginning on March 5, 2027; and (ii) 13,334 shares, which will vest in two equal annual installments beginning on April 1, 2027. Also includes 41,667 restricted stock units, which will vest in eight equal semi-annual installments beginning on October 6, 2026 (subject to continuous employment with the Issuer and/or its affiliates).
Open filing 0001104659-26-040955 Read from the filing’s XML Dispute this row
2026-04-06 Filed 2026-04-08Sim Kenneth T. Director · Officer: Executive Chairman
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)100,0000—739,407Direct (D) No
F5, F6
  • F5 Represents a grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Provided the Reporting Person is still employed with the Issuer and/or its affiliates on the date of vesting, the shares shall vest in eight equal semi-annual installments beginning on October 6, 2026.
  • F6 Includes the following shares of unvested restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer and/or its affiliates): (i) 78,334 shares, which will vest in two equal annual installments beginning on March 5, 2027; and (ii) 66,667 shares, which will vest in two equal annual installments beginning on April 1, 2027. Also includes 100,000 restricted stock units, which will vest in eight equal semi-annual installments beginning on October 6, 2026 (subject to continuous employment with the Issuer and/or its affiliates).
Open filing 0001104659-26-040952 Read from the filing’s XML Dispute this row
2026-04-06 Filed 2026-04-08Sim Brandon Officer: CEO and President
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)201,0560—1,246,385Direct (D) No
F3, F4, F5
  • F3 Represents a grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares shall vest in eight equal semi-annual installments beginning on October 6, 2026.
  • F4 Includes the following shares of unvested restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 29,919 shares, which will vest on June 27, 2026; and (ii) 34,207 shares, which will vest in two equal semi-annual installments, beginning September 30, 2026. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 60,347 restricted stock units, which will vest in four equal semi-annual installments beginning on October 2, 2026; (ii) 109,232 restricted stock units, which will vest in six equal semi-annual installments beginning on September 5, 2026; and (iii) 201,056 restricted stock units, which will vest in eight equal semi-annual installments beginning on October 6, 2026.
  • F5 Includes 1,420 shares acquired under the Issuer's Employee Stock Purchase Plan.
Open filing 0001104659-26-040951 Read from the filing’s XML Dispute this row
2026-04-02 Filed 2026-04-03Basho Chandan Officer: COO and CFO
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)2,09225.05
52,404.6

Derived: shares × price per share. Exact value 52404.60.

171,635Direct (D) No
F1, F2
  • F1 Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock units that vested on April 2, 2026.
  • F2 Includes the following shares of unvested restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 7,214 shares, which will vest on April 14, 2026; and (ii) 30,404 shares, which will vest in two equal annual installments on May 16, 2026 and 2027. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 15,604 restricted stock units, which will vest in four equal semi-annual installments beginning on October 2, 2026; and (ii) 20,027 restricted stock units, which will vest in six equal semi-annual installments beginning on September 5, 2026.
Open filing 0001104659-26-039686 Read from the filing’s XML Dispute this row
2026-04-01 Filed 2026-04-03Kumar Dinesh M. Officer: Chief Medical Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)35,3000—235,635Direct (D) No
F1
  • F1 Shares delivered to the reporting person pursuant to the vesting of performance-based restricted stock units that vested upon achievement of performance goals for the applicable performance period. The reporting person reported an acquisition of 67,238 performance-based restricted stock units on a Form 4 filed November 12, 2024, which represented the number of shares that would be delivered if target performance was achieved during the performance period. Actual performance exceeded the target performance for the performance period, which resulted in an additional grant of 35,300 shares.
Open filing 0001104659-26-039688 Read from the filing’s XML Dispute this row
2026-04-01 Filed 2026-04-03Kumar Dinesh M. Officer: Chief Medical Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)57,98024.51
1,421,089.8

Derived: shares × price per share. Exact value 1421089.80.

177,655Direct (D) No
F2, F3, F4
  • F2 Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock and restricted stock units that vested on April 1, 2026.
  • F3 Includes 28,378 shares of restricted stock, which will vest on January 23, 2027 (subject to continuous employment with the Issuer). Also includes 20,027 restricted stock units, which will vest in six equal semi-annual installments beginning on September 5, 2026 (subject to continuous employment with the Issuer).
  • F4 Includes 1,405 shares acquired under the Issuer's Employee Stock Purchase Plan.
Open filing 0001104659-26-039688 Read from the filing’s XML Dispute this row
2026-03-26 Filed 2026-03-30Sobotka Glenn Officer: Chief Accounting Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)66224.27
16,066.74

Derived: shares × price per share. Exact value 16066.74.

14,039Direct (D) No
F1, F2
  • F1 Represents the surrender of shares to offset against tax withholding obligations associated with certain shares of restricted stock that vested on March 26, 2026.
  • F2 Includes the following shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 4,824 shares, which will vest in three equal annual installments beginning on March 26, 2027; and (ii) 8,269 shares, which will vest subject to the achievement of certain performance goals.
Open filing 0001104659-26-036820 Read from the filing’s XML Dispute this row
2026-03-05 Filed 2026-03-09Kumar Dinesh M. Officer: Chief Medical Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)1,69725.07
42,543.79

Derived: shares × price per share. Exact value 42543.79.

200,335Direct (D) No
F1, F2, F3
  • F1 Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock units that vested on March 5, 2026.
  • F2 Includes the following shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 28,378 shares, which will vest on January 23, 2027; and (ii) grants of 8,158 shares and 3,264 shares, each of which will vest subject to the achievement of certain performance goals. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 67,238 restricted stock units, which will vest subject to the achievement of certain performance goals; and (ii) 20,027 restricted stock units, which will vest in six equal semi-annual installments beginning on September 5, 2026.
  • F3 Includes 1,405 shares acquired under the Issuer's Employee Stock Purchase Plan.
Open filing 0001104659-26-025234 Read from the filing’s XML Dispute this row
2026-03-05 Filed 2026-03-09Lam Thomas S. Director
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)9,26625.07
232,298.62

Derived: shares × price per share. Exact value 232298.62.

423,990Direct (D) No
F2, F3
  • F2 Represents the surrender of shares to offset against tax withholding obligations associated with shares of restricted stock that vested on March 5, 2026.
  • F3 Includes the following shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 51,667 shares, which will vest in two equal annual installments beginning on March 5, 2027; and (ii) 26,667 shares, which will vest upon achievement of certain pre-established performance goals.
Open filing 0001104659-26-025236 Read from the filing’s XML Dispute this row
2026-03-05 Filed 2026-03-09Basho Chandan Officer: COO and CFO
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)1,24025.07
31,086.8

Derived: shares × price per share. Exact value 31086.80.

173,727Direct (D) No
F1, F2
  • F1 Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock units that vested on March 5, 2026.
  • F2 Includes the following shares of unvested restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 7,214 shares, which will vest on April 14, 2026; and (ii) 30,404 shares, which will vest in two equal annual installments on May 16, 2026 and 2027. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 19,504 restricted stock units, which will vest in five equal semi-annual installments beginning on April 2, 2026; and (ii) 20,027 restricted stock units, which will vest in six equal semi-annual installments beginning on September 5, 2026.
Open filing 0001104659-26-025232 Read from the filing’s XML Dispute this row
2026-02-02 Filed 2026-02-03Sim Brandon Officer: CEO and President
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)21,33423.24
495,802.16

Derived: shares × price per share. Exact value 495802.16.

1,045,329Direct (D) No
F3, F4
  • F3 Includes the following shares of unvested restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 29,919 shares, which will vest on June 27, 2026; and (ii) 51,309 shares, which will vest in three equal semi-annual installments, beginning March 31, 2026. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 75,433 restricted stock units, which will vest in five equal semi-annual installments beginning on April 2, 2026; and (ii) 127,437 restricted stock units, which will vest in seven equal semi-annual installments beginning on March 5, 2026.
  • F4 Includes 1,420 shares acquired under the Issuer's Employee Stock Purchase Plan.
Open filing 0001104659-26-009940 Read from the filing’s XML Dispute this row
2026-02-02 Filed 2026-02-03Sim Brandon Officer: CEO and President
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (right to buy) — underlying Common Stock (21,334) — exercise price 23.24
Disposed (D)21,3340—0Direct (D) No
F5
  • F5 These stock options were fully vested and exercisable.
Open filing 0001104659-26-009940 Read from the filing’s XML Dispute this row
2026-01-23 Filed 2026-01-27Kumar Dinesh M. Officer: Chief Medical Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)10,75927.16
292,214.44

Derived: shares × price per share. Exact value 292214.44.

202,032Direct (D) No
F1, F2, F3
  • F1 Represents the surrender of shares to offset against tax withholding obligations associated with certain shares of restricted stock that vested on January 23, 2026.
  • F2 Includes the following shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 28,378 shares, which will vest on January 23, 2027; and (ii) grants of 8,158 shares and 3,264 shares, each of which will vest subject to the achievement of certain performance goals. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 67,238 restricted stock units, which will vest subject to the achievement of certain performance goals; and (ii) 23,364 restricted stock units, which will vest in seven equal semi-annual installments beginning on March 5, 2026.
  • F3 Includes 1,405 shares acquired under the Issuer's Employee Stock Purchase Plan.
Open filing 0001104659-26-007035 Read from the filing’s XML Dispute this row
2026-01-13 Filed 2026-01-15Schmidt David Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)20,0005.79
115,800

Derived: shares × price per share. Exact value 115800.00.

35,763Direct (D) No— Open filing 0001104659-26-004091 Read from the filing’s XML Dispute this row
2026-01-13 Filed 2026-01-15Schmidt David Director
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)4,26927.12
115,775.28

Derived: shares × price per share. Exact value 115775.28.

31,494Direct (D) No
F1
  • F1 Includes 6,449 shares of restricted stock, which will vest on the earlier of June 11, 2026 or the date of the Issuer's 2026 annual meeting of stockholders.
Open filing 0001104659-26-004091 Read from the filing’s XML Dispute this row
2026-01-13 Filed 2026-01-15Schmidt David Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (right to Buy) — underlying Common Stock (20,000) — exercise price 5.79
Disposed (D)20,0000—0Direct (D) No
F2
  • F2 These stock options were fully vested and exercisable.
Open filing 0001104659-26-004091 Read from the filing’s XML Dispute this row
2026-01-01 Filed 2026-01-05Kumar Dinesh M. Officer: Chief Medical Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)5,10224.81
126,580.62

Derived: shares × price per share. Exact value 126580.62.

212,791Direct (D) No
F1, F2, F3
  • F1 Represents the surrender of shares to offset against tax withholding obligations associated with certain shares of restricted stock that vested on January 1, 2026.
  • F2 Includes the following shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 56,754 shares, which will vest in two equal annual installments beginning on January 23, 2026; and (ii) grants of 8,158 shares and 3,264 shares, each of which will vest subject to the achievement of certain performance goals. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 67,238 restricted stock units, which will vest subject to the achievement of certain performance goals; and (ii) 23,364 restricted stock units, which will vest in seven equal semi-annual installments beginning on March 5, 2026.
  • F3 Includes 1,405 shares acquired under the Issuer's Employee Stock Purchase Plan.
Open filing 0001104659-26-000806 Read from the filing’s XML Dispute this row
2025-12-08 Filed 2025-12-10Lam Thomas S. Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)29,50217.78
524,545.56

Derived: shares × price per share. Exact value 524545.56.

459,122Direct (D) No— Open filing 0001104659-25-119985 Read from the filing’s XML Dispute this row
2025-12-08 Filed 2025-12-10Lam Thomas S. Director
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)25,86622
569,052

Derived: shares × price per share. Exact value 569052.

433,256Direct (D) No
F3
  • F3 Includes the following shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 77,500 shares, which will vest in three equal annual installments beginning on March 5, 2026; and (ii) 26,667 shares, which will vest upon achievement of certain pre-established performance goals.
Open filing 0001104659-25-119985 Read from the filing’s XML Dispute this row
2025-12-08 Filed 2025-12-10Lam Thomas S. Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (right to buy) — underlying Common Stock (29,502) — exercise price 17.78
Disposed (D)29,5020—0Direct (D) No
F2
  • F2 These stock options were fully vested and exercisable.
Open filing 0001104659-25-119985 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,925 filings read, the latest filed 2026-11-20. Prior quarter ending 2026-06-30: 9,176 filings read.

Showing 1–50 of 230

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
BlackRock, Inc. Partly reported under another manager7,391,882 SH262,929,242 dollarsHigher by 491,892 Prior quarter: 6,899,990Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
VANGUARD PORTFOLIO MANAGEMENT LLC 2,596,138 SH92,344,629 dollarsLower by 9,637 Prior quarter: 2,605,775Open filing 0002100121-26-001150 Filed 2026-11-13 Dispute this row
VANGUARD CAPITAL MANAGEMENT LLC 1,932,450 SH68,737,247 dollarsLower by 13,981 Prior quarter: 1,946,431Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row
STATE STREET CORP Partly reported under another manager1,769,654 SH62,946,593 dollarsHigher by 30,724 Prior quarter: 1,738,930Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row
DIMENSIONAL FUND ADVISORS LP Partly reported under another manager1,641,428 SH58,385,021 dollarsHigher by 172,920 Prior quarter: 1,468,508Open filing 0000354204-26-001096 Filed 2026-11-04 Dispute this row
325 CAPITAL LLC 1,613,843 SH57,404,396 dollarsUnchanged Prior quarter: 1,613,843Open filing 0001214659-26-014338 Filed 2026-11-16 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager1,215,029 SH43,226,381 dollarsHigher by 47,055 Prior quarter: 1,167,974Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
WELLS FARGO COMPANY/MN Partly reported under another manager1,089,608 SH38,757,356 dollarsHigher by 424,668 Prior quarter: 664,940Open filing 0000072971-26-000342 Filed 2026-11-16 Dispute this row
WELLINGTON MANAGEMENT GROUP LLP Partly reported under another manager1,073,550 SH38,186,173 dollarsLower by 219,023 Prior quarter: 1,292,573Open filing 0000902219-26-000323 Filed 2026-11-16 Dispute this row
FMR LLC Partly reported under another manager985,001 SH35,036,494 dollarsHigher by 299,079 Prior quarter: 685,922Open filing 0000315066-26-002964 Filed 2026-11-10 Dispute this row
BANK OF AMERICA CORP /DE/ Partly reported under another manager825,113 SH29,349,269 dollarsLower by 27,032 Prior quarter: 852,145Open filing 0000070858-26-000589 Filed 2026-11-16 Dispute this row
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 676,506 SH24,063,319 dollarsHigher by 23,837 Prior quarter: 652,669Open filing 0000884546-26-000417 Filed 2026-11-16 Dispute this row
MORGAN STANLEY Partly reported under another manager651,213 SH23,163,681 dollarsHigher by 217,705 Prior quarter: 433,508Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row
Diamond Hill Capital Management, LLC (Investment Advisor) 559,169 SH19,889,641 dollarsHigher by 83,228 Prior quarter: 475,941Open filing 0001217541-26-000011 Filed 2026-11-10 Dispute this row
NORTHERN TRUST CORP Partly reported under another manager496,040 SH17,644,141 dollarsLower by 9,004 Prior quarter: 505,044Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row
GOLDMAN SACHS GROUP INC Partly reported under another manager481,529 SH17,127,987 dollarsHigher by 209,731 Prior quarter: 271,798Open filing 0000886982-26-000647 Filed 2026-11-16 Dispute this row
JANE STREET GROUP, LLC Option: Call Partly reported under another manager456,500 SH16,237,705 dollarsHigher by 445,800 Prior quarter: 10,700Open filing 0001595888-26-000162 Filed 2026-11-12 Dispute this row
HOTCHKIS WILEY CAPITAL MANAGEMENT LLC 445,294 SH15,839,108 dollarsHigher by 195,884 Prior quarter: 249,410Open filing 0001172661-26-005357 Filed 2026-11-16 Dispute this row
SteelPeak Wealth, LLC 435,144 SH15,478,073 dollarsLower by 29,793 Prior quarter: 464,937Open filing 0001801868-26-000005 Filed 2026-10-16 Dispute this row
ROYCE ASSOCIATES LP 419,222 SH14,911,727 dollarsLower by 53,258 Prior quarter: 472,480Open filing 0000906304-26-000218 Filed 2026-11-09 Dispute this row
BNP PARIBAS FINANCIAL MARKETS Partly reported under another manager349,644 SH12,436,837 dollarsHigher by 251,650 Prior quarter: 97,994Open filing 0001166588-26-000012 Filed 2026-11-12 Dispute this row
Invesco Ltd. Partly reported under another manager344,532 SH12,255,003 dollarsLower by 37,298 Prior quarter: 381,830Open filing 0000914208-26-000462 Filed 2026-11-12 Dispute this row
VANGUARD FIDUCIARY TRUST CO 304,384 SH10,826,939 dollarsLower by 2,638 Prior quarter: 307,022Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row
PRINCIPAL FINANCIAL GROUP INC Partly reported under another manager276,931 SH9,850,436 dollarsHigher by 9,225 Prior quarter: 267,706Open filing 0001126328-26-000225 Filed 2026-11-02 Dispute this row
683 Capital Management, LLC Partly reported under another manager240,000 SH8,536,801 dollarsHigher by 30,000 Prior quarter: 210,000Open filing 0001404574-26-000027 Filed 2026-11-16 Dispute this row
Bank of New York Mellon Corp Partly reported under another manager229,276 SH8,155,358 dollarsLower by 5,620 Prior quarter: 234,896Open filing 0001390777-26-000121 Filed 2026-11-05 Dispute this row
Public Sector Pension Investment Board 226,966 SH8,580,450 dollarsHigher by 47,220 Prior quarter: 179,746Open filing 0001396318-26-000039 Filed 2026-11-10 Dispute this row
LPL Financial LLC 221,951 SH7,894,797 dollarsHigher by 255 Prior quarter: 221,696Open filing 0001403438-26-000005 Filed 2026-11-06 Dispute this row
EARNEST PARTNERS LLC 220,348 SH7,837,778 dollarsLower by 38,643 Prior quarter: 258,991Open filing 0001102578-26-000053 Filed 2026-11-12 Dispute this row
UBS Group AG Partly reported under another manager197,250 SH7,016,182 dollarsHigher by 5,294 Prior quarter: 191,956Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row
CITADEL ADVISORS LLC Partly reported under another manager175,286 SH6,234,923 dollarsHigher by 150,217 Prior quarter: 25,069Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row
ENVESTNET ASSET MANAGEMENT INC 167,024 SH5,941,044 dollarsLower by 20,438 Prior quarter: 187,462Open filing 0001214659-26-014231 Filed 2026-11-16 Dispute this row
JACOBS LEVY EQUITY MANAGEMENT, INC 166,584 SH5,925,393 dollarsLower by 18,317 Prior quarter: 184,901Open filing 0000884414-26-000004 Filed 2026-11-16 Dispute this row
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC 160,362 SH31,099 dollarsHigher by 137,905 Prior quarter: 22,457Open filing 0001214659-26-012804 Filed 2026-10-13 Dispute this row
NorthCrest Asset Manangement, LLC 159,495 SH5,721,086 dollarsHigher by 137,598 Prior quarter: 21,897Open filing 0001214659-26-012760 Filed 2026-10-13 Dispute this row
BNP PARIBAS ASSET MANAGEMENT Holding S.A. Partly reported under another manager154,146 SH5,482,973 dollarsLower by 181 Prior quarter: 154,327Open filing 0001520354-26-000046 Filed 2026-11-13 Dispute this row
1492 Capital Management LLC 145,955 SH5,191,619 dollarsHigher by 9 Prior quarter: 145,946Open filing 0001584087-26-000009 Filed 2026-11-12 Dispute this row
Emerald Investment Advisers, LLC 143,771 SH5,113,934 dollarsHigher by 28,726 Prior quarter: 115,045Open filing 0001104659-26-124239 Filed 2026-11-09 Dispute this row
F/m Investments LLC 143,771 SH5,113,934 dollarsNot in the prior quarter’s filings read Open filing 0001834499-26-000012 Filed 2026-11-13 Dispute this row
Insight Wealth Strategies, LLC Partly reported under another manager139,664 SH4,967,848 dollarsLower by 3,625 Prior quarter: 143,289Open filing 0001749914-26-000006 Filed 2026-10-09 Dispute this row
SEI INVESTMENTS CO Partly reported under another manager128,137 SH4,557,819 dollarsHigher by 4,923 Prior quarter: 123,214Open filing 0000350894-26-000059 Filed 2026-11-10 Dispute this row
Empowered Funds, LLC Partly reported under another manager127,053 SH4,519,275 dollarsLower by 8,726 Prior quarter: 135,779Open filing 0001592828-26-000008 Filed 2026-11-13 Dispute this row
Nuveen, LLC Partly reported under another manager124,794 SH4,438,923 dollarsLower by 8,028 Prior quarter: 132,822Open filing 0000930413-26-003284 Filed 2026-11-10 Dispute this row
Quantinno Capital Management LP 123,263 SH4,384,465 dollarsHigher by 52,740 Prior quarter: 70,523Open filing 0001759654-26-000011 Filed 2026-11-13 Dispute this row
TOWLE CO 122,801 SH4,368,032 dollarsLower by 62 Prior quarter: 122,863Open filing 0001224014-26-000008 Filed 2026-11-12 Dispute this row
AMERIPRISE FINANCIAL INC Partly reported under another manager118,346 SH4,209,568 dollarsLower by 393,764 Prior quarter: 512,110Open filing 0001193125-26-463125 Filed 2026-11-16 Dispute this row
RHUMBLINE ADVISERS 104,891 SH3,730,950 dollarsLower by 2,217 Prior quarter: 107,108Open filing 0001115418-26-000015 Filed 2026-11-10 Dispute this row
ADAGE CAPITAL PARTNERS GP, L.L.C. 100,520 SH3,575,496 dollarsNot in the prior quarter’s filings read Open filing 0001172661-26-005200 Filed 2026-11-16 Dispute this row
BARCLAYS PLC Partly reported under another manager96,425 SH3,429,838 dollarsHigher by 77,539 Prior quarter: 18,886Open filing 0000312069-26-000241 Filed 2026-11-06 Dispute this row
Legal General Group Plc Partly reported under another manager95,135 SH3,383,952 dollarsLower by 3,017 Prior quarter: 98,152Open filing 0001495115-26-000075 Filed 2026-11-16 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • Sixth Street Partners Management Company, L.P. 652,669 SH
  • MILLENNIUM MANAGEMENT LLC 190,503 SH
  • Penserra Capital Management LLC 63,424 SH
  • Inspire Investing, LLC 57,024 SH
  • Integrated Quantitative Investments LLC 36,922 SH
  • Walleye Capital LLC 35,267 SH
  • Tidal Investments LLC 20,987 SH
  • Jupiter Topco LLC 20,106 SH
  • ExodusPoint Capital Management, LP 12,743 SH
  • Baader Bank Aktiengesellschaft 12,000 SH
  • COMMONWEALTH EQUITY SERVICES, LLC 11,910 SH
  • HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 11,875 SH
  • nVerses Capital, LLC 10,891 SH
  • CAXTON ASSOCIATES LLP 9,766 SH
  • Curated Wealth Partners LLC 8,174 SH
  • Pathstone Holdings, LLC 5,957 SH
  • NEUBERGER BERMAN GROUP LLC 5,825 SH
  • Strategic Financial Concepts, LLC 5,541 SH
  • Pictet Asset Management Holding SA 5,510 SH
  • BOLTON SECURITIES CORPORATION 5,000 SH
  • MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC 4,862 SH
  • Olympiad Research LP 4,854 SH
  • PRELUDE CAPITAL MANAGEMENT, LLC 4,843 SH
  • SMITH SHELLNUT WILSON LLC /ADV 4,616 SH
  • CANADA PENSION PLAN INVESTMENT BOARD 4,600 SH
  • XPONANCE LLC 4,375 SH
  • Kemnay Advisory Services Inc. 3,550 SH
  • MERCER GLOBAL ADVISORS INC /ADV 1,733 SH
  • SIMPLEX TRADING, LLC 1,600 SH
  • BERTHEL, FISHER COMPANY FINANCIAL SERVICES, INC. 1,368 SH
  • NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 63 SH
  • Integrated Wealth Concepts LLC 29 SH
  • Plante Moran Financial Advisors, LLC 6 SH
  • Evolution Advisers, Inc. 3 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • Reports for quarters ending before 2013-06-30 were filed as plain text and are not read.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

Showing 1–2 of 2

House members’ trades in this company, newest report first, as filed
MemberTransaction dateTypeAmountOwnerReport
Hon. Judy Chu (CA28)2025-08-19Purchase$100,001 - $250,000SP2025-08-30
Hon. Judy Chu (CA28)2025-08-19Sale$100,001 - $250,000SP2025-08-30

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
Vanguard Portfolio Management Common Stock4.742,642,65509/30/2026 Filed 2026-10-30SCHEDULE 13G/AAmendment 1Open filing 0002100121-26-001050 Dispute this row
Vanguard Portfolio Management Common Stock5.342,648,93906/30/2026 Filed 2026-07-31SCHEDULE 13GOpen filing 0002100121-26-000920 Dispute this row
The Vanguard Group Common Stock0003/13/2026 Filed 2026-03-26SCHEDULE 13G/AAmendment 5Open filing 0000102909-26-000699 Dispute this row
The Vanguard Group Common Stock8.454,238,19212/31/2025 Filed 2026-01-30SCHEDULE 13G/AAmendment 4Open filing 0000102909-26-000054 Dispute this row
The Vanguard Group Common Stock9.684,833,38406/30/2025 Filed 2025-07-29SCHEDULE 13G/AAmendment 3Open filing 0000932471-25-000783 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,686,506 filings read, dated 2004-06-14 to 2026-11-20: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
2015103,592
2016222,642
2017222,009
2018223,345
2019216,482
2020226,343
2021249,835
2022231,682
2023229,674
2024234,045
2025235,520
2026263,124

Filings made before the SEC required XML are listed, not extracted.

Back to Astrana Health, Inc.